Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury
Authors:
Open Access
- 17 April 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 103 (1) , 111-120
Abstract
It is well-established that exercise diminishes cardiovascular risk, but whether humoral factors secreted by muscle confer these benefits has not been conclusively shown. We have shown that the secreted protein follistatin-like 1 (Fstl1) has beneficial actions on cardiac and endothelial function. However, the role of muscle-derived Fstl1 in proliferative vascular disease remains largely unknown. Here, we investigated whether muscle-derived Fstl1 modulates vascular remodelling in response to injury. The targeted ablation of Fstl1 in muscle led to an increase in neointimal formation following wire-induced arterial injury compared with control mice. Conversely, muscle-specific Fstl1 transgenic (TG) mice displayed a decrease in the neointimal thickening following arterial injury. Muscle-specific Fstl1 ablation and overexpression increased and decreased, respectively, the frequency of BrdU-positive proliferating cells in injured vessels. In cultured human aortic smooth muscle cells (HASMCs), treatment with human FSTL1 protein decreased proliferation and migration induced by stimulation with PDGF-BB. Treatment with FSTL1 enhanced AMPK phosphorylation, and inhibition of AMPK abrogated the inhibitory actions of FSTL1 on HASMC responses to PDGF-BB. The injured arteries of Fstl1-TG mice exhibited an increase in AMPK phosphorylation, and administration of AMPK inhibitor reversed the anti-proliferative actions of Fstl1 on the vessel wall. Our findings indicate that muscle-derived Fstl1 attenuates neointimal formation in response to arterial injury by suppressing SMC proliferation through an AMPK-dependent mechanism. Thus, the release of protein factors from muscle, such as Fstl1, may partly explain why the maintenance of muscle function can have a therapeutic effect on the cardiovascular system.Keywords
This publication has 48 references indexed in Scilit:
- Muscles, exercise and obesity: skeletal muscle as a secretory organNature Reviews Endocrinology, 2012
- AMPKα2 Deletion Exacerbates Neointima Formation by Upregulating Skp2 in Vascular Smooth Muscle CellsCirculation Research, 2011
- Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overloadProceedings of the National Academy of Sciences, 2011
- Oversecretion of interleukin-15 from skeletal muscle reduces adiposityAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- FGF21 is an Akt‐regulated myokineFEBS Letters, 2008
- Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategiesNature Medicine, 2002
- Akt Mediates Cytoprotection of Endothelial Cells by Vascular Endothelial Growth Factor in an Anchorage-dependent MannerJournal of Biological Chemistry, 1999
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- The biology of restenosisProgress in Cardiovascular Diseases, 1997